Clinical Trials Arena July 29, 2024
The blood-brain barrier is the biggest hurdle in treating brain diseases, and research on overcoming this challenge is ongoing.
With the 2024 edition of the Alzheimer’s Association International Conference (AAIC) underway in Philadelphia until 1 August, research into approaches to treating Alzheimer’s disease continues at pace. And it is no surprise, given the number of people living with the condition continues to rise and few drugs are available on the market for treatment.
Alzheimer’s is the most common form of dementia. Alzheimer’s Disease International (ADI) estimates there were more than 55 million people worldwide living with dementia in 2020 and anticipates this number will almost double every 20 years, reaching 78 million in 2030 and 139 million in 2050.
Earlier...